Concepedia

Author

Ricardo Parrondo

Mayo Clinic in FloridaORCID

Also Known As

Parrondo R, R. D. Parrondo, R. Parrondo, Ricardo D Parrondo, Ricardo D. Parrondo, Ricardo Daniel Parrondo, Ricardo Parrondo

244

Publications

1.4K

Citations

20

H-Index

43

Concepts

All Affiliations

Mayo Clinic in FloridaMayo Clinic in ArizonaWinnMedMayo ClinicUniversity of Miami
RP

About

Ricardo Parrondo is an author at Mayo Clinic in Florida specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

339

2

Cell Biology

7

7

245

3

Health Sciences

1

1

34

4

Natural Sciences

1

1

76

5

Biochemistry

1

1

76

Ricardo Parrondo

×

35

Publications

1K

Citations

18

H-Index

YearCitations

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres,

Blood

2024

92

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Roque Díaz, Paul Nguewa, Ricardo Parrondo,

BMC Cancer

2010

85

Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity

Teresita Reiner, Ricardo Parrondo, Alicia de las Pozas,

PLoS ONE

2013

76

NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells

Ricardo Parrondo, Alicia de las Pozas, Teresita Reiner,

Molecular Cancer

2010

62

First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)

John F. Seymour, Chan Y. Cheah, Ricardo Parrondo,

Blood

2023

59

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells

Ricardo Parrondo, Alicia de las Pozas, Teresita Reiner,

PeerJ

2013

54

Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage

Teresita Reiner, Alicia de las Pozas, Ricardo Parrondo,

Oncoscience

2015

45

Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature

Saranya Chumsri, Ethan S. Sokol, Aixa E. Soyano‐Muller,

Journal of the National Comprehensive Cancer Network

2020

43

In-Hospital Mortality and Post-Transplantation Complications in Elderly Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Population-Based Study

Larysa Sanchez, Michael Sylvester, Ricardo Parrondo,

Biology of Blood and Marrow Transplantation

2017

35

Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).

Doris K. Hansen, Krina K. Patel, Lauren C. Peres,

Journal of Clinical Oncology

2023

34

Page 1